活动交流
您当前位置:首页科学研究科研进展
Journal of Experimental & Clinical Cancer Research (IF: 6.217) 刊登本中心 研究文章Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of beta-catenin stabilization in cancer stem cells
2019-09-27
0

Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of beta-catenin stabilization in cancer stem cells 鞣花酸直接抑制ACTN4调节肿瘤干细胞中β-连环蛋白的稳定性而限制乳腺癌转 移 

第一作者：王能 

通讯作者：王志宇，谢晓明 

来源出版物：Journal of Experimental & Clinical Cancer Research 卷：36 文献号： 9 DOI：10.1186/s13046-017-0635-9 出版年：DEC 2 2017 

Journal of Experimental & Clinical Cancer Research IF: 6.217（2018）, JCR Oncology Q1分区，中科院医学大类2区，肿瘤学小类2区

Journal of Experimental & Clinical Cancer Research (IF: 6.217) 刊登本中心 研究文章Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of beta-catenin stabilization in cancer stem cells

上一篇:Scientific Reports (IF: 4.122) 刊登本中心研究文章Network-pharmacologybased validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis下一篇:Biomedicine & pharmacotherapy (IF: 3.743) 刊登本中心研究文章Networkpharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis

管理人员

教学文件
相关活动
暂无数据